The global gastrointestinal stents market size was valued at USD 314.8 million in 2016 and is expected to grow at a CAGR of 4.7% over the forecast period. Factors such as increasing geriatric population who have stomach or digestive cancer and gradually stabilizing the prices of these devices in emerging countries of Asia and Latin America are driving the growth of the market.
Furthermore, increasing adoption of minimally invasive procedures is propelling the growth of the gastrointestinal (GI) stents market. These devices are becoming the preferred choice for the management of various gastrointestinal diseases due to certain benefits it provides over conventional products in terms of reduced blood loss, lesser chances of infection, shorter hospital stay, and quick recovery.
Biliary stents dominated the product segment in 2016 with the largest revenue share. Biliary stents are used to treat obstructions that occur in the bile ducts. Currently, minimally invasive endoscopic stent placement has evolved to be one of the most successful treatment options for life-threatening benign bile duct structures. This is the key factor resulting in the largest revenue share of the segment.
Moreover, the esophageal stent segment is expected to grow at the highest CAGR during the forecast period since it is an important tool for palliative treatment of inoperable esophageal malignancies.
The biliary diseases segment dominated the overall application sector in 2016. Most of the players have biliary stents as one of their prime products, which is used by hospitals and clinics for palliative treatment of biliary diseases.
The market for Esophageal stenting, which includes treating ulcerative colitis, Crohn’s disease, esophageal cancer, and pancreatic cancer, is expected to exhibit the highest growth during the forecast period. Increasing adoption of biodegradable stents for the management of esophageal and pancreatic cancer which results in good palliation for patients in their remaining life span, without any serious risks and complication, would boost the growth of the market.
North America dominated the global market with the largest revenue share in 2016. High adoption of minimally invasive surgeries, favorable reimbursement policies, and high rate of new cases diagnosed are some of the prime factors resulting in larger revenue generation in the region.
Asia Pacific is expected to grow at the fastest rate during the forecast period. Factors such as increasing incidence of stomach cancer are expected to drive the growth in the region. The booming medical tourism industry in the region owing to availability of the advanced medical treatments at a cheaper cost is anticipated to expand the patient base in the region. As a result, demand for GI stents is expected to rise significantly in Asia Pacific during the forecast period.
Currently, the global market is highly fragmented with a number of players competing with each other. Some of the players operating in the sector are Boston Scientific, Cook Medical, ELLA-CS, s.r.o., ConMed, Gore Medical, TaeWoong Medical, Hobbs Medical, Inc., C.R. Bard, Merit Endotek, Olympus America and Esophageal stent. Regional expansion, mergers, and acquisition of local players are some of the key strategies adopted by international players to remain competent in the market.
Report Attribute |
Details |
Market size value in 2020 |
USD 373.7 million |
Revenue forecast in 2025 |
USD 472.5 million |
Growth Rate |
CAGR of 4.7% from 2017 to 2025 |
Base year for estimation |
2016 |
Historical data |
2014 - 2015 |
Forecast period |
2017 - 2025 |
Quantitative units |
Revenue in USD million and CAGR from 2017 to 2025 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
Segments covered |
Product, application, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; Japan; China; Brazil; Mexico; South Africa |
Key companies profiled |
Boston Scientific; Cook Medical; ELLA-CS; s.r.o.; ConMed; Gore Medical; TaeWoong Medical; Hobbs Medical, Inc.; C.R. Bard; Merit Endotek; Olympus America |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional & country levels as well as provides an analysis on the latest trends and opportunities in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global gastrointestinal stents market on the basis of product, application, and region:
Product Outlook (Revenue, USD Million, 2014 - 2025)
Biliary Stent
Duodenal Stent
Colonic Stent
Pancreatic Stent
Esophageal Stent
Application Outlook (Revenue, USD Million, 2014 - 2025)
Biliary Disease
Colorectal Cancer
Stomach Cancer
Others
Regional Outlook (Revenue, USD Million, 2014 - 2025)
North America
The U.S.
Canada
Europe
The U.K.
Germany
Asia Pacific
Japan
China
Latin America
Brazil
Mexico
MEA
South Africa
b. The global gastrointestinal stents market size was estimated at USD 357.6 million in 2019 and is expected to reach USD 373.7 million in 2020.
b. The global gastrointestinal stents market is expected to grow at a compound annual growth rate of 4.7% from 2018 to 2025 to reach USD 472.5 million by 2025.
b. North America dominated the gastrointestinal stents market with a share of 45.5% in 2019. This is attributable to the high adoption of minimally invasive surgeries, favorable reimbursement policies, and high rate of new cases diagnosed.
b. Some key players operating in the gastrointestinal stents market include Boston Scientific, Cook Medical, ELLA-CS, s.r.o., ConMed, Gore Medical, TaeWoong Medical, Hobbs Medical, Inc., C.R. Bard, Merit Endotek, Olympus America.
b. Key factors that are driving the market growth include increasing adoption of minimally invasive procedures, booming medical tourism industry and increasing prevalence of various gastrointestinal diseases.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.
We value your investment and offer free customization with every report to fulfil your exact research needs.